Critical appraisal on "Assessing the cost-effectiveness of once-weekly somatrogon vs. daily somatropin for pediatric growth hormone deficiency"

J Med Econ. 2024 Jan-Dec;27(1):907-909. doi: 10.1080/13696998.2024.2374644. Epub 2024 Jul 8.
No abstract available

MeSH terms

  • Child
  • Cost-Benefit Analysis*
  • Drug Administration Schedule
  • Growth Disorders / drug therapy
  • Growth Disorders / economics
  • Human Growth Hormone* / administration & dosage
  • Human Growth Hormone* / deficiency
  • Human Growth Hormone* / economics
  • Human Growth Hormone* / therapeutic use
  • Humans

Substances

  • Human Growth Hormone